amygdalin and Cancer of Prostate

amygdalin has been researched along with Cancer of Prostate in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Afshari, JT; Alwan, AM1
Gao, W; Hou, J; Liu, Y; Rao, J; Zhou, C; Zhou, J1
Hantash, J1
Blaheta, RA; Chun, FK; Juengel, E; Mani, J; Maxeiner, S; Neuschäfer, J; Resch, C; Roos, F; Rutz, J1
Bartsch, G; Blaheta, RA; Borgmann, H; Haferkamp, A; Juengel, E; Makarević, J; Nelson, K; Thomas, C; Tsaur, I1
Chang, HK; Kim, CJ; Kim, J; Kim, KH; Kim, YS; Lee, JW; Lee, MH; Shin, MS; Yang, HY1
Yarbro, JW1

Other Studies

7 other study(ies) available for amygdalin and Cancer of Prostate

ArticleYear
    BioMed research international, 2022, Volume: 2022

    Topics: Adenocarcinoma; Amygdalin; Animals; Doxorubicin; Humans; Male; Mice; Mice, Nude; Prostate; Prostatic Neoplasms

2022
Magnetically Directed Enzyme/Prodrug Prostate Cancer Therapy Based on β-Glucosidase/Amygdalin.
    International journal of nanomedicine, 2020, Volume: 15

    Topics: Amygdalin; Animals; Antineoplastic Agents, Phytogenic; beta-Glucosidase; Cell Line, Tumor; Enzymes, Immobilized; Humans; Magnetic Fields; Magnetic Phenomena; Male; Mice, Inbred C57BL; Nanoparticles; Polyethylene Glycols; Prodrugs; Prostatic Neoplasms; Starch

2020
The use of polysulfated polysaccharides heparin like compounds, glycosaminoglycans and Vitamin B17 as a possible treatment for prostate cancer.
    Medical hypotheses, 2018, Volume: 112

    Topics: Adenocarcinoma; Amygdalin; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Drug Combinations; Drug Synergism; Extracellular Matrix; Glycosaminoglycans; Heparitin Sulfate; Humans; Injections, Intravenous; Male; Models, Biological; Myocytes, Smooth Muscle; Polysaccharides; Prostate; Prostatic Neoplasms; Vitamin A; Vitamin E

2018
Amygdalin Modulates Prostate Cancer Cell Adhesion and Migration In Vitro.
    Nutrition and cancer, 2020, Volume: 72, Issue:3

    Topics: Amygdalin; Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Line, Tumor; Cell Movement; Chemotaxis; Collagen; Humans; Integrin alpha2; Integrin alpha6; Integrin beta1; Integrins; Male; Prostatic Neoplasms

2020
Amygdalin delays cell cycle progression and blocks growth of prostate cancer cells in vitro.
    Life sciences, 2016, Feb-15, Volume: 147

    Topics: Amygdalin; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Male; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Time Factors

2016
Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells.
    Biological & pharmaceutical bulletin, 2006, Volume: 29, Issue:8

    Topics: Amygdalin; Apoptosis; Base Sequence; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Caspases; Cell Line, Tumor; DNA Primers; Humans; In Situ Nick-End Labeling; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2006
Laetrile 'case histories': a review and critique.
    Missouri medicine, 1979, Volume: 76, Issue:4

    Topics: Adult; Aged; Amygdalin; Animals; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Quackery; Uterine Cervical Neoplasms

1979